Non-pharmaceutical treatment combats recurring Clostridium Difficile infections
Transplanting human donor fecal microbiota into the colon of a patient infected with Clostridiodes difficile (C. diff) may be the best treatment for those not helped by C. diff targeted antibiotics, according to an article in the Journal of the American Osteopathic Association.
C. diff is the most common healthcare-acquired infection in the United States. It affects nearly half a million patients each year and becomes a recurring infection for nearly a third of them. If untreated, C. diff can lead to sepsis and death.
“Twenty five years ago C. diff infections were easier to manage and often resolved with discontinuation of the initiating antibiotic,” says Robert Orenstein, DO, an infectious disease specialist at Mayo Clinic and lead author on this article. “However, these infections have become increasingly common and pernicious.”
The standard and FDA-approved treatment for C. diff is a course of oral vancomycin, an antibiotic. However, even the medications used to eliminate C. diff can perpetuate the infection by killing off beneficial microbes. Newer antibiotics that more specifically target C. diff have been developed but they can be prohibitively expensive, according to Dr. Orenstein.
“Think of your gut as a forest and C. diff as a weed,” says Dr. Orenstein. “In a thriving forest, weeds barely get a foothold. But if you burn the forest down, the weeds are going to flourish.”
Unlike antibiotics, which are destructive by definition, fecal transplants or microbial replacement therapies, repopulate the gut with a diverse group of microbes that may block the C. diff‘s spore from germinating and propagating disease via its toxins. Transplants have several delivery methods, including enemas, capsules and direct instillation, to replace the diverse flora that maintain health and improve metabolism.
Currently, there are no FDA-approved fecal transplant products and performing fecal transplants is considered an investigational procedure. Dr. Orenstein notes there are several companies with products in Phase 3 clinical trials that could come to market as early as 2020. For this reason he strongly urges healthcare providers to refer patients with recurrent C. diff for these trials rather than for fecal transplants. In the meantime, the FDA reserves fecal transplants for patients who have experienced a second recurrence (third episode) of C. diff infection.
C. diff is common in healthcare settings and public spaces and rarely causes problems in people with healthy gut microbiota and immune systems, according to researchers. However, people who are already ill and taking antibiotics, chemotherapy, or proton pump inhibitors–which all greatly disrupt the gut ecosystem–are at risk. Elderly patients are especially vulnerable.
Dr. Orenstein expects the new treatment options will improve outcomes but says physicians need to assume greater responsibility for prevention.
“One of the most effective things physicians can do is become more responsible with antibiotic prescriptions,” says Dr. Orenstein. “That means only prescribing when they are clearly indicated, not for colds or viral sinus infections. We also must be especially judicious with elderly patients.”
Learn more: Mayo Clinic doctors: Fecal transplants may be best answer to antibiotic-resistant bacteria
The Latest on: Fecal transplants
[google_news title=”” keyword=”fecal transplants” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Fecal transplants
- B.C. naturopath banned from making fecal transplants for autistic kids loses again in courton March 17, 2023 at 10:25 am
Jason Klop was seeking leave to appeal a B.C. Supreme Court decision in support of the ban stopping him from producing pills and enemas made from human feces.
- Would You Take a Poop Pill?on March 15, 2023 at 5:00 pm
But even I cringed when I learned that researchers are now investigating fecal transplant pills. In other words, poop pills. Fecal microbiota transplant (FMT) research has shown a lot of promise for ...
- The Future of Feceson March 1, 2023 at 1:13 am
Fecal transplants are being heralded as a simple cure for a dangerous and growing intestinal infection. But their future is uncertain. The answer to her woes, it turns out, was feces. Oakland ...
- Fecal Microbiota Transplantation News and Researchon February 18, 2023 at 3:59 pm
Fecal microbiota transplantation (FMT) – the transfer of lower intestinal fluids and microbes from one individual to another – is sometimes used to treat inflammatory gut diseases, including ...
- ADVENTURES IN FOOD AND FITNESS: Fecal transplants help Fort Wayne patients suffering from deadly diarrheaon February 4, 2023 at 4:00 pm
You must be exceptionally fit — inside and out – to provide material for the process known as fecal microbial transplant (FMT), in which stool containing desirable gut bacteria is inserted ...
- Fecal Transplants Boost Helpful Microbiota for Stem Cell Transplant Patientson May 15, 2022 at 10:14 pm
After learning she would need a cord blood transplant to treat her leukemia, Bridget Anderson decided to enroll in a clinical trial testing the benefits of fecal microbiota transplants. After ...
- Poop pills: Fecal transplants show promise in reducing insulin sensitivity: U of Aon July 5, 2021 at 12:54 pm
A recent study at the University of Alberta has found fecal transplants plus fibre supplements help to improve insulin sensitivity in severely obese people. A six-week clinical trial at the U of A ...
- This Poop Transplant Resulted In A Death, FDA Warningon June 15, 2019 at 4:29 am
Well, death, for one thing. A death is the reason why the U.S. Food and Drug Administration (FDA) has just issued a warning about fecal transplants or FMT, which stands for fecal microbiota for ...
via Bing News